Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

627
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
627
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.1K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.1K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

407
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
407
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

548
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
548
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

307
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
307
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

258
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pain medicine aspects of the updated S2k guideline "Diagnosis and treatment of endometriosis"].

Schmerz (Berlin, Germany)·2026
Same author

Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

Pharmacopsychiatry·2026
Same author

Symptom-Level Comorbidity of Fibromyalgia and Depression: A Network Approach within a Large Clinical Sample.

Psychotherapy and psychosomatics·2026
Same author

Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Disorders of Gut-Brain Interaction.

Gastroenterology·2026
Same author

German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.

Journal of clinical medicine·2026
Same author

Graded chronic pain scale revised: validation in a sample of the general German Population.

Pain medicine (Malden, Mass.)·2026
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

755

[Functional gastrointestinal disorders].

Winfried Häuser, Viola Andresen

    Deutsche Medizinische Wochenschrift (1946)
    |May 11, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Functional gastrointestinal disorders (FGID) affect half of chronic GI symptoms. Evidence-based guidelines improve diagnosis and management, integrating biopsychosocial factors for better patient care.

    More Related Videos

    Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
    03:48

    Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

    Published on: March 1, 2024

    1.3K
    Chronic Salmonella Infection Induced Intestinal Fibrosis
    08:40

    Chronic Salmonella Infection Induced Intestinal Fibrosis

    Published on: September 22, 2019

    7.3K

    Related Experiment Videos

    Last Updated: Sep 23, 2025

    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
    06:01

    Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

    Published on: July 26, 2024

    755
    Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
    03:48

    Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

    Published on: March 1, 2024

    1.3K
    Chronic Salmonella Infection Induced Intestinal Fibrosis
    08:40

    Chronic Salmonella Infection Induced Intestinal Fibrosis

    Published on: September 22, 2019

    7.3K

    Area of Science:

    • Gastroenterology
    • Psychiatry
    • Primary Care Medicine

    Background:

    • Functional gastrointestinal disorders (FGID) account for approximately 50% of chronic gastrointestinal symptoms in primary care.
    • Common FGID include functional dyspepsia and irritable bowel syndrome, characterized by heterogeneity in symptoms, impairment, and pathophysiology.
    • The biopsychosocial model and the Rome Foundation define FGID as disorders of brain-gut interaction.

    Purpose of the Study:

    • To highlight challenges in FGID diagnosis and management, including physician hesitancy and patient reluctance.
    • To emphasize the importance of interdisciplinary, evidence-based guidelines for improving diagnostic certainty and therapeutic options.
    • To provide recommendations for patient education and establishing a trusting doctor-patient relationship.

    Main Methods:

    • Diagnosis relies on characteristic symptom clusters and exclusion of organic gastrointestinal disorders per guidelines.
    • Management follows a graduated approach based on main symptoms, patient impairment, and preferences.
    • Treatment strategies include education, dietary modifications, pharmacological interventions, and psychological therapies.

    Main Results:

    • Interdisciplinary guidelines enhance diagnostic confidence and expand therapeutic choices for FGID.
    • Guidelines offer strategies for effective patient communication, fostering trust and acceptance of the FGID diagnosis.
    • A structured, symptom-based management plan improves patient outcomes.

    Conclusions:

    • Evidence-based guidelines are crucial for optimizing the diagnosis and management of functional gastrointestinal disorders.
    • A biopsychosocial approach, integrated with patient-centered care, is essential for addressing FGID effectively.
    • Effective communication and graduated treatment plans are key to successful FGID management.